Login
Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Password:
Stay Logged In


Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Peptides  >  Thrombospondins  >>  LSKL, Inhibitor of Thrombospondin (TSP-1)

Product Name LSKL, Inhibitor of Thrombospondin (TSP - 1)
LSKL - NH2
Size 1 mg
Catalog # 60877
US$ $66
Purity % Peak Area By HPLC ≥ 95%
Description

This peptide, derived from the latency-associated peptide, inhibits thrombospondin (TSP-1) activation of TGF-; thus preventing the progression of hepatic damage and fibrosis.

Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Storage -20C
References Ref: Ribeiro, SM. et al. J. Biol. Chem. 274, 13586 (1999); Kondou, H. et al. J. Hepatol. 39, 742 ( 2003).
Molecular Weight 458.6
Sequence
(One-Letter Code)
LSKL-NH2
Sequence
(Three-Letter Code)
H - Leu - Ser - Lys - Leu - NH2
Product Citations Wang, S. et al. (2010). Glucose downregulation of PKG-I protein mediates increased thrombospondin1-dependent TGF-β activity in vascular smooth muscle cells. Am J Physiol Cell Physiol doi:10.1152/ajpcell.00330.2009
Xie, X. et al. (2010). LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction. Archives Pharmac Research 33, 275.
Belmadani, Souad. A. J. Pathology. 171, 777 (2007).
Zhou, Y. et al. Am. J. Pathol. 165, 659 (2004).
Meek, R. L. et al. Am J Physiol Renal Physiol. 285, 79 (2003).
     
  < Back